Edition:
United States

Blueprint Medicines Corp (BPMC.OQ)

BPMC.OQ on NASDAQ Stock Exchange Global Select Market

67.03USD
20 Nov 2017
Change (% chg)

-- (--)
Prev Close
$67.03
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
143,996
52-wk High
$74.42
52-wk Low
$25.08

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 8.07 -0.964
Jun '17 5.89 -0.862
Mar '17 5.84 -0.843
FY 2016 Dec '16 7.69 -0.747
Sep '16 6.16 -0.618
Jun '16 7.07 -0.695
Mar '16 6.86 -0.572
FY 2015 Dec '15 4.64 -0.576
Sep '15 3.43 -0.471
Jun '15 2.69 -0.811
Mar '15 0.65 -8.234
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 8 4.99 8.10 1.12 6.34
Quarter Ending Mar-18 6 4.07 6.00 1.12 --
Year Ending Dec-17 9 24.67 28.00 20.92 26.83
Year Ending Dec-18 9 13.89 29.40 1.70 23.73
Earnings (per share)
Quarter Ending Dec-17 9 -1.12 -1.02 -1.37 -0.99
Quarter Ending Mar-18 7 -1.15 -0.96 -1.41 --
Year Ending Dec-17 9 -3.81 -3.71 -4.06 -4.20
Year Ending Dec-18 9 -4.87 -4.09 -5.93 -4.55
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 200.64 34.68
P/E High - Last 5 Yrs. -- 292.78 45.18
P/E Low - Last 5 Yrs. -- 96.53 24.20
Beta -- 0.85 0.89
Price to Sales (TTM) 95.59 94.15 5.28
Price to Book (MRQ) 7.70 20.33 5.58
Price to Tangible Book (MRQ) 7.70 23.70 7.10
Price to Cash Flow (TTM) -- 105.38 23.65
% Owned Institutions -- 6.14 1.28

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.03
Dividend 5 Year Growth Rate -- 2.06 5.31
Payout Ratio(TTM) -- 108.76 45.48

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 30.97 5.37 6.93
Sales (TTM) vs TTM 1 Yr. Ago 11.22 28.55 5.15
Sales - 5 Yr. Growth Rate -- 33.75 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago -55.98 -142.75 4.86
EPS (TTM) vs TTM 1 Yr. Ago -38.76 -- --
EPS - 5 Yr. Growth Rate -- 44.56 11.02
Capital Spending - 5 Yr. Growth Rate -- 41.86 15.11

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.54
Current Ratio (MRQ) 11.28 5.57 3.55
LT Debt to Equity (MRQ) 0.08 14.39 12.26
Total Debt to Equity (MRQ) 0.61 16.74 18.26
Interest Coverage (TTM) -123.61 -144.04 43.11

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.96 54.73
Gross Margin - 5 Yr. Avg. -- 55.13 52.22
EBITD Margin (TTM) -439.98 -- --
EBITD - 5 Yr. Avg -- -209.76 15.69
Operating Margin (TTM) -445.73 -530.58 8.10
Operating Margin - 5 Yr. Avg. -- -225.54 11.33
Pre-Tax Margin (TTM) -437.83 -498.47 8.95
Pre-Tax Margin - 5 Yr. Avg. -- -225.32 11.74
Net Profit Margin (TTM) -437.83 -495.61 5.18
Net Profit Margin - 5 Yr. Avg. -- -228.41 8.02
Effective Tax Rate (TTM) -- 15.63 24.21
Effective Tax Rate - 5 Yr. Avg. -- 19.29 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 259,330 22,793,534 864,771,004
Net Income/Employee (TTM) -1,135,425 -1,249,347 100,828,627
Receivable Turnover (TTM) 7.98 33.23 6.12
Inventory Turnover (TTM) -- 2.68 3.51
Asset Turnover (TTM) 0.09 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -40.94 -7.78 11.38
Return on Assets - 5 Yr. Avg. -- 0.15 12.41
Return on Investment (TTM) -45.58 -10.01 14.55
Return on Investment - 5 Yr. Avg. -- 3.38 16.25
Return on Equity (TTM) -54.84 -35.77 16.07
Return on Equity - 5 Yr. Avg. -- 6.10 17.40
  1 Year 3 Year 5 Year
Sales % 143.61 -- --
EPS (TTM) % 14.01 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Blueprint Medicines Corp

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.98 0.31 65 77
13 Week 58.02 48.61 90 47
26 Week 67.99 55.76 89 70
52 Week 84.45 55.86 85 45
YTD 138.97 107.19 93 47
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 205
Total Shares Held: 39,731,524
3 Mo. Net Change: 249,480
# New Positions: 33
# Closed Positions: 16
# Increased Positions: 93
# Reduced Positions: 76
# Net Buyers: 17
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.